Correlates of Bleeding Events Among Moderate- to High-Risk Patients Undergoing Percutaneous Coronary Intervention and Treated With Eptifibatide: Observations From the PROTECT-TIMI-30 Trial -- Kirtane et al., 10.1016/j.jacc.2005.09.080 -- Journal of the American College of Cardiology

Advertisement


		Search

2012 ACCF/ AATS/ SCAI/ STS Expert Consensus Document on Transcatheter Aortic Valve Replacement

ACCF/ SCAI/ STS/ AATS/ AHA/ ASNC/ HFSA/ SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

2012 ACCF/ AHA/ ACR/ SCAI/ SIR/ STS/ SVM/ SVN Key Data Elements and Definitions for Peripheral Atherosclerotic Vascular Disease


	About JACC CME
	Policy on Privacy and Confidentiality
	Disclosures
	Important Information


Still not a subscriber to JACC Imaging or JACC Interventions? Click here to sign up now!


	Submit Manuscripts
	Author Information
	Subscribe/Renew
	Order Reprints
	Email Alerts
	Feedback
	RSS Feed
	CME


	Cardiosmart
	Cardiosource
	CVN
	Imaging Library
	JACC Imaging
	JACC Interventions


	About the Journal
	Editorial Board & Staff

	Help viewing high resolution images
	Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.

Figure 4 Relation of dose adjustment of eptifibatide infusion to bleeding. CrCl = creatinine clearance.

Return to article

Advertisement